Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Avalyn to Participate in Jefferies Global Healthcare Conference
-
ceτi AI Receives $2 Million Worth of H100 GPUs at T3 Data Center
-
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
-
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
-
Lilium Jet to Take Flight in the French Riviera in 2026
-
Ihsan Essaid Appointed Chief Financial Officer of QXO
-
Solowin Announces Strategic Partnership with MaiCapital to Expand Virtual Asset Allocation Opportunities
-
Gorilla Technology and SINTRONES Partner to Develop In-Vehicle AI Computing Capabilities
-
Foresight Announces First Quarter 2024 Financial Results
-
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
-
Kandi Shines at Thailand Golf Cart Expo, Expands in Southeast Asia
-
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
-
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
-
NEVADA CANYON SIGNS LAPON CANYON ROYALTY AGREEMENT
-
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
-
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
-
iLearningEngines Expects to Join the Russell 3000® Index
-
Cerro de Pasco Resources is Granted a Long-Awaited Land Easement for its Quiulacocha Project, Peru
-
Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
-
Latest Survey from Grayscale Investments® and The Harris Poll Uncovers Likely American Voters Increasingly Becoming Crypto Investors
-
CryptoHeap to Include Major Cryptocurrencies in Updated Staking Options
-
Lantheus to Present at the William Blair 44th Annual Growth Stock Conference
-
DYPER™ Announces Appointment of Giusy Buonfantino as New CEO
-
Tokio Marine HCC – Specialty Group and Susan G. Komen® Pair Up With World No. 1 Golfer Nelly Korda to Help End Breast Cancer
-
Invitation to ScottsMiracle-Gro’s “Meet the Management” Investor Day in Marysville, Ohio
-
Nano® Hearing Aids and Soundwave Hearing Forge Strategic Partnership to Expand Accessibility to Sontro® Self-Fitting OTC Hearing Aid
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
Kratos Defense Celebrates the 200th Launch of the BQM-177A in Support of U.S. Navy Exercises
-
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
LevLane Advertising Wins PRSA Anvil Award for Best Feature Article Addressing Bias Against Use of Biological Terms in Women's Health Marketing and Advertising
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Decisions of the Annual General Meeting of AS Pro Kapital Grupp shareholders
-
Wood Mackenzie names new leader for Consulting
-
Alliance Trust PLC - Net Asset Value
-
NeuralAI Launches AI 3D Asset Generator with TAO Bittensor Subnet: Transforming 3D Model Creation for Games and Beyond
-
CAE, INC. ALERT: CAE, Inc. Falls after Announcing Impairment Charges (NYSE: CAE) – Investors are Encouraged to Contact BFA Law About Your Rights
-
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermat
-
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
-
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
-
Inter&Co doubles down on SMEs through acquisition of Granito
-
Inter&Co doubles down on SMEs through acquisition of Granito
-
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (NYSE: WOW) – Contact BFA Law to Discuss How this Impacts You
-
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYSE: SQSP) - Contact BFA Law to Discuss How this Impacts You
-
Yorbeau Consolidates Interest in Its Beschefer Property
-
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
-
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
-
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
-
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

